Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neuroblastoma 4Multiple Myeloma 2Vaccinia 1Transplant-Related Hematologic Malignancy 1Recurrence 1Prostatic Neoplasms 1Oligodendroglioma 1Neoplasms 1Medulloblastoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Kidney Neoplasms 1Hodgkin Disease 1Glioma 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Ipilimumab 5pembrolizumab 4Axitinib 4cabozantinib 3Nivolumab 3Blood Specimen Collection 3zimberelimab 2atezolizumab 2Surveys and Questionnaires 2Sunitinib 2Irinotecan 2trebananib 1temsirolimus 1spartalizumab 1salicylhydroxamic acid 1palbociclib 1orellanine 1olaparib 1liposomal doxorubicin 1lenvatinib 1gallium Ga 68 dotatate 1fludarabine 1brodalumab 1belzutifan 1aldesleukin 1adagrasib 1X-Rays 1Vincristine 1Temozolomide 1Technetium Tc 99m Sestamibi 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Granulocyte-Macrophage Colony-Stimulating Factor × 90 days × Clear all
NCT00458536 2026-05-19

Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF

Beth Israel Deaconess Medical Center

Phase 1/2 Completed
38 enrolled 4 charts
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡